drugset / Trial / NCT02640417

Nucleotides and B Vitamins in the Treatment of Low Back Pain

NCT02640417

Phase 4 Completed 300 enrolled Fundação Educacional Serra dos Órgãos
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a double-blind, randomized study in parallel groups of subjects presenting with low back pain. Randomized subjects will receive treatment for 60 days with either a combination of nucleotides and vitamin B12 or vitamin B1+B6+B12.

Timeline

Start
2016-03
Primary completion
2018-03
Completion
2018-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Cytidine Small molecule Oral
Comparator Pyridoxine Unknown Oral
Comparator Thiamine Other / unclassified Oral
Subject Uridine Small molecule Oral
Background Vitamin B12 Other / unclassified Oral

Indications

No indication recorded.